Voluntary announcement a phase iii clinical trial of lp-003 for the indication of seasonal ar met primary endpoints

Jun 11, 2026 at 10:11 PM UTC · Issued by Longbio Pharma (suzhou) Co., Ltd. Class H via HKEXnews

Longbio Pharma (suzhou) Co., Ltd. Class H (1779) Press Release